{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:08:45Z","timestamp":1789229325340,"version":"build-2803163510"},"reference-count":70,"publisher":"Keio Journal of Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2020]]},"DOI":"10.2302\/kjm.2019-0012-oa","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T18:04:21Z","timestamp":1585332261000},"page":"77-87","source":"Crossref","is-referenced-by-count":13,"title":["Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by          Genetic Research, Toward Future Therapy"],"prefix":"10.2302","volume":"69","author":[{"given":"Takeharu","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Physiology, Tokai University School of Medicine, Kanagawa,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Braunwald E: Cardiomyopathies. Circ Res 2017;          121: 711\u2013721. PMID:28912178, DOI:10.1161\/CIRCRESAHA.117.311812","DOI":"10.1161\/CIRCRESAHA.117.311812"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. McKenna WJ, Maron BJ, Thiene G: Classification,          epidemiology, and global burden of cardiomyopathies. Circ Res 2017; 121: 722\u2013730.          PMID:28912179, DOI:10.1161\/CIRCRESAHA.117.309711","DOI":"10.1161\/CIRCRESAHA.117.309711"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada          Y, Hayashi T, Amano K: Giant T wave inversion as a manifestation of asymmetrical apical          hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic          study. Jpn Heart J 1976; 17: 611\u2013629. PMID:136532, DOI:10.1536\/ihj.17.611","DOI":"10.1536\/ihj.17.611"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Maron MS, Olivotto I, Betocchi S, Casey SA,          Lesser JR, Losi MA, Cecchi F, Maron BJ: Effect of left ventricular outflow tract          obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348:          295\u2013303. PMID:12540642, DOI:10.1056\/NEJMoa021332","DOI":"10.1056\/NEJMoa021332"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Efthimiadis GK, Pagourelias ED, Parcharidou D,          Gossios T, Kamperidis V, Theofilogiannakos EK, Pappa Z, Meditskou S, Hadjimiltiades S,          Pliakos C, Karvounis H, Styliadis IH: Clinical characteristics and natural history of          hypertrophic cardiomyopathy with midventricular obstruction. Circ J 2013; 77: 2366\u20132374.          PMID:23728066, DOI:10.1253\/circj.CJ-12-1561","DOI":"10.1253\/circj.CJ-12-1561"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller          FO: Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United          States, 1980-2006. Circulation 2009; 119: 1085\u20131092. PMID:19221222,          DOI:10.1161\/CIRCULATIONAHA.108.804617","DOI":"10.1161\/CIRCULATIONAHA.108.804617"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Maron BJ, Gardin JM, Flack JM, Gidding SS,          Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of          young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation          1995; 92: 785\u2013789. PMID:7641357, DOI:10.1161\/01.CIR.92.4.785","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Teare D: Asymmetrical hypertrophy of the heart in          young adults. Heart 1958; 20: 1\u20138. PMID:13499764, DOI:10.1136\/hrt.20.1.1","DOI":"10.1136\/hrt.20.1.1"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Braunwald E, Lambrew CT, Rockoff SD, Ross J,          Morrow AG: Idiopathic hypertrophic subaortic stenosis. I. A description of the disease          based upon an analysis of 64 patients. Circulation 1964; 29(Suppl 4): 4, 3\u2013119.          PMID:14227306, DOI:10.1161\/01.CIR.29.5S4.IV-3","DOI":"10.1161\/01.CIR.29.5S4.IV-3"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Par\u00e9 JA, Fraser RG, Pirozynski WJ, Shanks JA,          Stubington D: Hereditary cardiovascular dysplasia. Am J Med 1961; 31: 37\u201362.          PMID:13732753, DOI:10.1016\/0002-9343(61)90222-4","DOI":"10.1016\/0002-9343(61)90222-4"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Jarcho JA, McKenna W, Pare JA, Solomon SD,          Holcombe RF, Dickie S, Levi T, Donis-Keller H, Seidman JG, Seidman CE: Mapping a gene for          familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989; 321:          1372\u20131378. PMID:2811944, DOI:10.1056\/NEJM198911163212005","DOI":"10.1056\/NEJM198911163212005"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Geisterfer-Lowrance AA, Kass S, Tanigawa G,          Vosberg HP, McKenna W, Seidman CE, Seidman JG: A molecular basis for familial hypertrophic          cardiomyopathy: A \u03b2 cardiac myosin heavy chain gene missense mutation. Cell 1990; 62:          999\u20131006. PMID:1975517, DOI:10.1016\/0092-8674(90)90274-I","DOI":"10.1016\/0092-8674(90)90274-I"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Bonne G, Carrier L, Bercovici J, Cruaud C,          Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg HP,          Fiszman M, Komajda M, Schwartz K: Cardiac myosin binding protein-C gene splice acceptor          site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995; 11:          438\u2013440. PMID:7493026, DOI:10.1038\/ng1295-438","DOI":"10.1038\/ng1295-438"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Watkins H, Conner D, Thierfelder L, Jarcho JA,          MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE: Mutations in the cardiac myosin          binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat          Genet 1995; 11: 434\u2013437. PMID:7493025, DOI:10.1038\/ng1295-434","DOI":"10.1038\/ng1295-434"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Thierfelder L, Watkins H, MacRae C, Lamas R,          McKenna W, Vosberg HP, Seldman JG, Seidman CE: \u03b1-Tropomyosin and cardiac troponin T          mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell          1994; 77: 701\u2013712. PMID:8205619, DOI:10.1016\/0092-8674(94)90054-X","DOI":"10.1016\/0092-8674(94)90054-X"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Kimura A, Harada H, Park JE, Nishi H, Satoh M,          Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA,          Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H,          Koga Y, Imaizumi T, Sasazuki T: Mutations in the cardiac troponin I gene associated with          hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379\u2013382. PMID:9241277,          DOI:10.1038\/ng0897-379","DOI":"10.1038\/ng0897-379"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Poetter K, Jiang H, Hassanzadeh S, Master SR,          Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND: Mutations in either          the essential or regulatory light chains of myosin are associated with a rare myopathy in          human heart and skeletal muscle. Nat Genet 1996; 13: 63\u201369. PMID:8673105,          DOI:10.1038\/ng0596-63","DOI":"10.1038\/ng0596-63"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Olson TM, Doan TP, Kishimoto NY, Whitby FG,          Ackerman MJ, Fananapazir L: Inherited and de novo mutations in the cardiac actin gene          cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32: 1687\u20131694. PMID:10966831,          DOI:10.1006\/jmcc.2000.1204","DOI":"10.1006\/jmcc.2000.1204"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Lankford EB, Epstein ND, Fananapazir L, Sweeney          HL: Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain          gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995; 95:          1409\u20131414. PMID:7883988, DOI:10.1172\/JCI117795","DOI":"10.1172\/JCI117795"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman          JG, Warshaw DM: Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse          model of familial hypertrophic cardiomyopathy. Circ Res 2000; 86: 737\u2013744. PMID:10764406,          DOI:10.1161\/01.RES.86.7.737","DOI":"10.1161\/01.RES.86.7.737"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yanaga F, Morimoto S, Ohtsuki I: Ca2+          sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused          by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem          1999; 274: 8806\u20138812. PMID:10085122, DOI:10.1074\/jbc.274.13.8806","DOI":"10.1074\/jbc.274.13.8806"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Bottinelli R, Coviello DA, Redwood CS, Pellegrino          MA, Maron BJ, Spirito P, Watkins H, Reggiani C: A mutant tropomyosin that causes          hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium          sensitivity. Circ Res 1998; 82: 106\u2013115. PMID:9440709,          DOI:10.1161\/01.RES.82.1.106","DOI":"10.1161\/01.RES.82.1.106"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Elliott K, Watkins H, Redwood CS: Altered          regulatory properties of human cardiac troponin I mutants that cause hypertrophic          cardiomyopathy. J Biol Chem 2000; 275: 22069\u201322074. PMID:10806205,          DOI:10.1074\/jbc.M002502200","DOI":"10.1074\/jbc.M002502200"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Marston S, Copeland ON, Gehmlich K, Schlossarek          S, Carrier L: How do MYBPC3 mutations cause hypertrophic cardiomyopathy? J Muscle Res Cell          Motil 2012; 33: 75\u201380. PMID:22057632, DOI:10.1007\/s10974-011-9268-3","DOI":"10.1007\/s10974-011-9268-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.Kimura A. Molecular etiology and pathogenesis          of hereditary cardiomyopathy. Circ J 2008; 72 Suppl A:A38-48.","DOI":"10.1253\/circj.CJ-08-0050"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Cazorla O, Wu Y, Irving TC, Granzier H:          Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac          myocytes. Circ Res 2001; 88: 1028\u20131035. PMID:11375272,          DOI:10.1161\/hh1001.090876","DOI":"10.1161\/hh1001.090876"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo          F, Kimura A: Structural analysis of the titin gene in hypertrophic cardiomyopathy:          identification of a novel disease gene. Biochem Biophys Res Commun 1999; 262: 411\u2013417.          PMID:10462489, DOI:10.1006\/bbrc.1999.1221","DOI":"10.1006\/bbrc.1999.1221"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Matsumoto Y, Hayashi T, Inagaki N, Takahashi M,          Hiroi S, Nakamura T, Arimura T, Nakamura K, Ashizawa N, Yasunami M, Ohe T, Yano K, Kimura          A: Functional analysis of titin\/connectin N2-B mutations found in cardiomyopathy. J Muscle          Res Cell Motil 2006; 26: 367\u2013374. PMID:16465475,          DOI:10.1007\/s10974-005-9018-5","DOI":"10.1007\/s10974-005-9018-5"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Kn\u00f6ll R, Hoshijima M, Hoffman HM, Person V,          Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W,          Yokoyama M, Schork NJ, Omens JH, McCulloch AD, Kimura A, Gregorio CC, Poller W, Schaper J,          Schultheiss HP, Chien KR: The cardiac mechanical stretch sensor machinery involves a Z          disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002;          111: 943\u2013955. PMID:12507422, DOI:10.1016\/S0092-8674(02)01226-6","DOI":"10.1016\/S0092-8674(02)01226-6"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Hayashi T, Arimura T, Itoh-Satoh M, Ueda K, Hohda          S, Inagaki N, Takahashi M, Hori H, Yasunami M, Nishi H, Koga Y, Nakamura H, Matsuzaki M,          Choi BY, Bae SW, You CW, Han KH, Park JE, Kn\u00f6ll R, Hoshijima M, Chien KR, Kimura A: Tcap          gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll          Cardiol 2004; 44: 2192\u20132201. PMID:15582318,          DOI:10.1016\/j.jacc.2004.08.058","DOI":"10.1016\/j.jacc.2004.08.058"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF,          Shete S, Roberts R, Willerson JT, Marian AJ: Myozenin 2 is a novel gene for human          hypertrophic cardiomyopathy. Circ Res 2007; 100: 766\u2013768. PMID:17347475,          DOI:10.1161\/01.RES.0000263008.66799.aa","DOI":"10.1161\/01.RES.0000263008.66799.aa"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Landstrom AP, Weisleder N, Batalden KB, Martijn          Bos J, Tester DJ, Ommen SR, Wehrens XH, Claycomb WC, Ko JK, Hwang M, Pan Z, Ma J, Ackerman          MJ: Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy          in humans. J Mol Cell Cardiol 2007; 42: 1026\u20131035. PMID:17509612,          DOI:10.1016\/j.yjmcc.2007.04.006","DOI":"10.1016\/j.yjmcc.2007.04.006"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Minamisawa S, Sato Y, Tatsuguchi Y, Fujino T,          Imamura S, Uetsuka Y, Nakazawa M, Matsuoka R: Mutation of the phospholamban promoter          associated with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2003; 304: 1\u20134.          PMID:12705874, DOI:10.1016\/S0006-291X(03)00526-6","DOI":"10.1016\/S0006-291X(03)00526-6"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Hayashi T, Arimura T, Ueda K, Shibata H, Hohda S,          Takahashi M, Hori H, Koga Y, Oka N, Imaizumi T, Yasunami M, Kimura A: Identification and          functional analysis of a caveolin-3 mutation associated with familial hypertrophic          cardiomyopathy. Biochem Biophys Res Commun 2004; 313: 178\u2013184. PMID:14672715,          DOI:10.1016\/j.bbrc.2003.11.101","DOI":"10.1016\/j.bbrc.2003.11.101"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Arimura T, Bos JM, Sato A, Kubo T, Okamoto H,          Nishi H, Harada H, Koga Y, Moulik M, Doi YL, Towbin JA, Ackerman MJ, Kimura A: Cardiac          ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll          Cardiol 2009; 54: 334\u2013342. PMID:19608031, DOI:10.1016\/j.jacc.2008.12.082","DOI":"10.1016\/j.jacc.2008.12.082"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Minetti C, Sotgia F, Bruno C, Scartezzini P,          Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volont\u00e9 D, Galbiati F, Cordone          G, Bricarelli FD, Lisanti MP, Zara F: Mutations in the caveolin-3 gene cause autosomal          dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18: 365\u2013368. PMID:9537420,          DOI:10.1038\/ng0498-365","DOI":"10.1038\/ng0498-365"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Moreira ES, Wiltshire TJ, Faulkner G,          Nilforoushan A, Vainzof M, Suzuki OT, Valle G, Reeves R, Zatz M, Passos-Bueno MR, Jenne          DE: Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the          sarcomeric protein telethonin. Nat Genet 2000; 24: 163\u2013166. PMID:10655062,          DOI:10.1038\/72822","DOI":"10.1038\/72822"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Goldfarb LG, Park KY, Cerven\u00e1kov\u00e1 L, Gorokhova S,          Lee HS, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC: Missense          mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet          1998; 19: 402\u2013403. PMID:9697706, DOI:10.1038\/1300","DOI":"10.1038\/1300"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Harada H, Hayashi T, Nishi H, Kusaba K, Koga Y,          Koga Y, Nonaka I, Kimura A: Phenotypic expression of a novel desmin gene mutation:          hypertrophic cardiomyopathy followed by systemic myopathy. J Hum Genet 2018; 63: 249\u2013254.          PMID:29167554, DOI:10.1038\/s10038-017-0383-x","DOI":"10.1038\/s10038-017-0383-x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ghezzi D, Baruffini E, Haack TB, Invernizzi F,          Melchionda L, Dallabona C, Strom TM, Parini R, Burlina AB, Meitinger T, Prokisch H,          Ferrero I, Zeviani M: Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic          cardiomyopathy and lactic acidosis. Am J Hum Genet 2012; 90: 1079\u20131087. PMID:22608499,          DOI:10.1016\/j.ajhg.2012.04.011","DOI":"10.1016\/j.ajhg.2012.04.011"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Pasquale F, Syrris P, Kaski JP, Mogensen J,          McKenna WJ, Elliott P: Long-term outcomes in hypertrophic cardiomyopathy caused by          mutations in the cardiac troponin T gene. Circ Cardiovasc Genet 2012; 5: 10\u201317.          PMID:22144547, DOI:10.1161\/CIRCGENETICS.111.959973","DOI":"10.1161\/CIRCGENETICS.111.959973"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Page SP, Kounas S, Syrris P, Christiansen M,          Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ: Cardiac myosin binding protein-C          mutations in families with hypertrophic cardiomyopathy: disease expression in relation to          age, gender, and long term outcome. Circ Cardiovasc Genet 2012; 5: 156\u2013166. PMID:22267749,          DOI:10.1161\/CIRCGENETICS.111.960831","DOI":"10.1161\/CIRCGENETICS.111.960831"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Varnava AM, Elliott PM, Baboonian C, Davison F,          Davies MJ, McKenna WJ: Hypertrophic cardiomyopathy. Circulation 2001; 104: 1380\u20131384.          PMID:11560853, DOI:10.1161\/hc3701.095952","DOI":"10.1161\/hc3701.095952"},{"key":"44","unstructured":"44. Charron P, Carrier L, Dubourg O, Tesson F, Desnos          M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour JB, Mallet A, Feingold J, Schwartz          K, Komajda M: Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 1997; 8:          107\u2013114. PMID:9219008"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Ho CY, Charron P, Richard P, Girolami F, Van          Spaendonck-Zwarts KY, Pinto Y: Genetic advances in sarcomeric cardiomyopathies: state of          the art. Cardiovasc Res 2015; 105: 397\u2013408. PMID:25634555,          DOI:10.1093\/cvr\/cvv025","DOI":"10.1093\/cvr\/cvv025"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Tripathi S, Schultz I, Becker E, Montag J,          Borchert B, Francino A, Navarro-Lopez F, Perrot A, \u00d6zcelik C, Osterziel KJ, McKenna WJ,          Brenner B, Kraft T: Unequal allelic expression of wild-type and mutated \u03b2-myosin in          familial hypertrophic cardiomyopathy. Basic Res Cardiol 2011; 106: 1041\u20131055.          PMID:21769673, DOI:10.1007\/s00395-011-0205-9","DOI":"10.1007\/s00395-011-0205-9"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Oikawa M, Sakamoto N, Kobayashi A, Suzuki S,          Yoshihisa A, Yamaki T, Nakazato K, Suzuki H, Saitoh S, Kiko Y, Nakano H, Hayashi T, Kimura          A, Takeishi Y: Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation          and zebra body. BMC Cardiovasc Disord 2016; 16: 83. PMID:27160240,          DOI:10.1186\/s12872-016-0262-y","DOI":"10.1186\/s12872-016-0262-y"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Elliott PM, Poloniecki J, Dickie S, Sharma S,          Monserrat L, Varnava A, Mahon NG, McKenna WJ: Sudden death in hypertrophic cardiomyopathy:          identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212\u20132218.          PMID:11127463, DOI:10.1016\/S0735-1097(00)01003-2","DOI":"10.1016\/S0735-1097(00)01003-2"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Maron BJ, Rowin EJ, Casey SA, Lesser JR,          Garberich RF, McGriff DM, Maron MS: Hypertrophic cardiomyopathy in children, adolescents,          and young adults associated with low cardiovascular mortality with contemporary management          strategies. Circulation 2016; 133: 62\u201373. PMID:26518766,          DOI:10.1161\/CIRCULATIONAHA.115.017633","DOI":"10.1161\/CIRCULATIONAHA.115.017633"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer          MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson          JE, Yancy CW: 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic          cardiomyopathy. A report of the American College of Cardiology Foundation\/American Heart          Association Task Force on Practice Guidelines. Circulation 2011; 124: e783\u2013e831.          PMID:22068434, DOI:10.1161\/CIR.0b013e318223e2bd","DOI":"10.1161\/CIR.0b013e318223e2bd"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Elliott PM, Anastasakis A, Borger MA, Borggrefe          M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ,          Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH,          Tillmanns C, Watkins H, Authors\/Task Force members: 2014 ESC Guidelines on diagnosis and          management of hypertrophic cardiomyopathy. Eur Heart J 2014; 35: 2733\u20132779. PMID:25173338,          DOI:10.1093\/eurheartj\/ehu284","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52. JCS Joint Working Group: Guidelines for Diagnosis          and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012) \u2013 Digest Version.          Circ J 2016; 80: 753\u2013774. PMID:26841693, DOI:10.1253\/circj.CJ-66-0122","DOI":"10.1253\/circj.CJ-66-0122"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53. Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM,          Colan SD, Chung WK, Jefferies JL, Rossano JW, Castleberry CD, Addonizio LJ, Lal AK, Lamour          JM, Miller EM, Thrush PT, Czachor JD, Razoky H, Hill A, Lipshultz SE: Pediatric          cardiomyopathies. Circ Res 2017; 121: 855\u2013873. PMID:28912187,          DOI:10.1161\/CIRCRESAHA.116.309386","DOI":"10.1161\/CIRCRESAHA.116.309386"},{"key":"54","doi-asserted-by":"publisher","unstructured":"54. Hayashi T, Tanimoto K, Hirayama-Yamada K, Tsuda          E, Ayusawa M, Nunoda S, Hosaki A, Kimura A: Genetic background of Japanese patients with          pediatric hypertrophic and restrictive cardiomyopathy. J Hum Genet 2018; 63: 989\u2013996.          PMID:29907873, DOI:10.1038\/s10038-018-0479-y","DOI":"10.1038\/s10038-018-0479-y"},{"key":"55","doi-asserted-by":"publisher","unstructured":"55. Morita H, Rehm HL, Menesses A, McDonough B,          Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE: Shared genetic causes of          cardiac hypertrophy in children and adults. N Engl J Med 2008; 358: 1899\u20131908.          PMID:18403758, DOI:10.1056\/NEJMoa075463","DOI":"10.1056\/NEJMoa075463"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56. Minami Y, Kajimoto K, Terajima Y, Yashiro B,          Okayama D, Haruki S, Nakajima T, Kawashiro N, Kawana M, Hagiwara N: Clinical implications          of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll          Cardiol 2011; 57: 2346\u20132355. PMID:21636036,          DOI:10.1016\/j.jacc.2011.02.033","DOI":"10.1016\/j.jacc.2011.02.033"},{"key":"57","doi-asserted-by":"publisher","unstructured":"57. Inagaki N, Hayashi T, Takei Y, Tanimoto K,          Chikamori T, Kimura A: Clinical and genetic backgrounds of hypertrophic cardiomyopathy          with mid-ventricular obstruction. J Hum Genet 2018; 63: 1273\u20131276. PMID:30206291,          DOI:10.1038\/s10038-018-0509-9","DOI":"10.1038\/s10038-018-0509-9"},{"key":"58","doi-asserted-by":"publisher","unstructured":"58. Semsarian C, Ahmad I, Giewat M, Georgakopoulos D,          Schmitt JP, McConnell BK, Reiken S, Mende U, Marks AR, Kass DA, Seidman CE, Seidman JG:          The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J          Clin Invest 2002; 109: 1013\u20131020. PMID:11956238, DOI:10.1172\/JCI200214677","DOI":"10.1172\/JCI200214677"},{"key":"59","doi-asserted-by":"publisher","unstructured":"59. Ho CY, Lakdawala NK, Cirino AL, Lipshultz SE,          Sparks E, Abbasi SA, Kwong RY, Antman EM, Semsarian C, Gonz\u00e1lez A, L\u00f3pez B, Diez J, Orav          EJ, Colan SD, Seidman CE: Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy          sarcomere\u00a0mutation carriers: a pilot randomized trial to modify disease expression. JACC          Heart Fail 2015; 3: 180\u2013188. PMID:25543971,          DOI:10.1016\/j.jchf.2014.08.003","DOI":"10.1016\/j.jchf.2014.08.003"},{"key":"60","doi-asserted-by":"publisher","unstructured":"60. Axelsson A, Iversen K, Vejlstrup N, Ho CY,          Havndrup O, Kofoed KF, Norsk J, Jensen M, Bundgaard H: Functional effects of losartan in          hypertrophic cardiomyopathy\u2014a randomised clinical trial. Heart 2016; 102: 285\u2013291.          PMID:26661322, DOI:10.1136\/heartjnl-2015-308343","DOI":"10.1136\/heartjnl-2015-308343"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61. Axelsson Raja A, Shi L, Day SM, Russell M, Zahka          K, Lever H, Colan SD, Margossian R, Hall EK, Becker J, Jefferies JL, Patel AR, Choudhury          L, Murphy AM, Canter C, Bach R, Taylor M, Mestroni L, Wheeler MT, Benson L, Owens AT,          Rossano J, Lin KY, Pahl E, Pereira AC, Bundgaard H, Lewis GD, Vargas JD, Cirino AL,          McMurray JJ, MacRae CA, Solomon SD, Orav EJ, Braunwald E, Ho CY: Baseline characteristics          of the VANISH cohort. Circ Heart Fail 2019; 12: e006231. PMID:31813281,          DOI:10.1161\/CIRCHEARTFAILURE.119.006231","DOI":"10.1161\/CIRCHEARTFAILURE.119.006231"},{"key":"62","doi-asserted-by":"publisher","unstructured":"62. Ashrafian H, Horowitz JD, Frenneaux MP:          Perhexiline. Cardiovasc Drug Rev 2007; 25: 76\u201397. PMID:17445089,          DOI:10.1111\/j.1527-3466.2007.00006.x","DOI":"10.1111\/j.1527-3466.2007.00006.x"},{"key":"63","doi-asserted-by":"publisher","unstructured":"63. Abozguia K, Elliott P, McKenna W, Phan TT,          Nallur-Shivu G, Ahmed I, Maher AR, Kaur K, Taylor J, Henning A, Ashrafian H, Watkins H,          Frenneaux M: Metabolic modulator perhexiline corrects energy deficiency and improves          exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 2010; 122:          1562\u20131569. PMID:20921440, DOI:10.1161\/CIRCULATIONAHA.109.934059","DOI":"10.1161\/CIRCULATIONAHA.109.934059"},{"key":"64","doi-asserted-by":"publisher","unstructured":"64. Green EM, Wakimoto H, Anderson RL, Evanchik MJ,          Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM, Song Y, Wan W, Leinwand          LA, Spudich JA, McDowell RS, Seidman JG, Seidman CE: A small-molecule inhibitor of          sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 2016; 351:          617\u2013621. PMID:26912705, DOI:10.1126\/science.aad3456","DOI":"10.1126\/science.aad3456"},{"key":"65","doi-asserted-by":"publisher","unstructured":"65. Heitner SB, Jacoby D, Lester SJ, Owens A, Wang A,          Zhang D, Lambing J, Lee J, Semigran M, Sehnert AJ: Mavacamten treatment for obstructive          hypertrophic cardiomyopathy. Ann Intern Med 2019; 170: 741\u2013748. PMID:31035291,          DOI:10.7326\/M18-3016","DOI":"10.7326\/M18-3016"},{"key":"66","doi-asserted-by":"publisher","unstructured":"66. Jiang J, Wakimoto H, Seidman JG, Seidman CE:          Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic          cardiomyopathy. Science 2013; 342: 111\u2013114. PMID:24092743,          DOI:10.1126\/science.1236921","DOI":"10.1126\/science.1236921"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67. Mearini G, Stimpel D, Geertz B, Weinberger F,          Kr\u00e4mer E, Schlossarek S, Mourot-Filiatre J, Stoehr A, Dutsch A, Wijnker PJ, Braren I,          Katus HA, M\u00fcller OJ, Voit T, Eschenhagen T, Carrier L: Mybpc3 gene therapy for neonatal          cardiomyopathy enables long-term disease prevention in mice. Nat Commun 2014; 5: 5515.          PMID:25463264, DOI:10.1038\/ncomms6515","DOI":"10.1038\/ncomms6515"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held          P, McMurray JJ, Michelson EL, Olofsson B, \u00d6stergren J, CHARM Investigators and Committees:          Effects of candesartan in patients with chronic heart failure and preserved          left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777\u2013781.          PMID:13678871, DOI:10.1016\/S0140-6736(03)14285-7","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"69","doi-asserted-by":"publisher","unstructured":"69. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand          IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF,          Kenwood CT, Lewis EF, O\u2019Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD,          Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators: Spironolactone for heart failure          with preserved ejection fraction. N Engl J Med 2014; 370: 1383\u20131392. PMID:24716680,          DOI:10.1056\/NEJMoa1313731","DOI":"10.1056\/NEJMoa1313731"},{"key":"70","doi-asserted-by":"publisher","unstructured":"70. Parenti G, Andria G, Valenzano KJ:          Pharmacological chaperone therapy: preclinical development, clinical translation, and          prospects for the treatment of lysosomal storage disorders. Mol Ther 2015; 23: 1138\u20131148.          PMID:25881001, DOI:10.1038\/mt.2015.62","DOI":"10.1038\/mt.2015.62"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/69\/4\/69_2019-0012-OA\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T22:34:05Z","timestamp":1608935645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/69\/4\/69_2019-0012-OA\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2019-0012-oa","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}